These mechanisms are also largely involved in the response to treatment with the IL30-targeting immunoliposome in the syngeneic model of IL30-overexpressing PC in fully immunocompetent hosts, of which the inhibition of angiogenesis and proliferation and the downmodulation of NFKB128 are hallmarks. This evidence concerns the gene IL27 and pachyonychia congenita.